TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Tataa Biocenter AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
4,701
|
3,300
|
9,212 |
Financial expenses |
1
|
32
|
0 |
Earnings before taxes |
-5,440
|
-5,437
|
-1,065 |
EBITDA |
-4,914
|
-4,897
|
409 |
Total assets |
3,947
|
3,984
|
6,753 |
Current assets |
2,414
|
2,037
|
4,290 |
Current liabilities |
1,288
|
2,390
|
4,182 |
Equity capital |
2,659
|
1,594
|
2,571 |
- share capital |
13
|
12
|
14 |
Employees (average) |
46
|
47
|
41 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
67.4%
|
40.0%
|
38.1% |
Turnover per employee |
102
|
70
|
225 |
Profit as a percentage of turnover |
-115.7%
|
-164.8%
|
-11.6% |
Return on assets (ROA) |
-137.8%
|
-135.7%
|
-15.8% |
Current ratio |
187.4%
|
85.2%
|
102.6% |
Return on equity (ROE) |
-204.6%
|
-341.1%
|
-41.4% |
Change turnover |
1,391
|
-5,166
|
1,321 |
Change turnover % |
42%
|
-61%
|
17% |
Chg. No. of employees |
-1
|
6
|
13 |
Chg. No. of employees % |
-2%
|
15%
|
46% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.